CellGenetic & Genomic MedicinePeer-reviewed journal article
CXCL12 drives natural variation in coronary artery anatomy in diverse populations
Pamela E. Rios CoronadoiD, Jiayan ZhouiD, Xiaochen FaniD, Daniela ZanettiiD, Jeffrey A. NaftalyiD, Pratima PrabalaiD, Azalia M. Martínez JaimesiD, Elie N. FarahiD, Soumya KunduiD, Salil DeshpandeiD, Ivy EvergreeniD, Pik Fang KhoiD, Qixuan MaiD, Austin T. HilliardiD, Sarah A. AbramowitziD, Saiju PyarajaniD, Daniel R. DochtermanniD, Scott M. DamraueriD, Kyong‐Mi ChangiD, Michael G. LeviniD, Virginia D. WinniD, Anca M. PașcaiD, Mary E. PlomondoniD, Stephen W. WaldoiD, Philip S. TsaoiD, , Themistocles L. AssimesiD
Abstract
To efficiently distribute blood flow to cardiac muscle, the coronary artery tree must follow a specific branching pattern over the heart. How this pattern arises in humans is unknown due to the limitations of studying human heart development. Here, we leveraged a natural variation of coronary artery anatomy, known as coronary dominance, in genetic association studies to identify the first known driver of human coronary developmental patterning. Coronary dominance refers to whether the right, left, or both coronary arteries branch over the posterior left ventricle, but whether this variability is heritable and how it would be genetically regulated was completely unknown. By conducting the first large-scale, multi-ancestry genome-wide association study (GWAS) of coronary dominance in 61,043 participants of the VA Million Veteran Program, we observed moderate heritability (27.7%) with ten loci reaching genome wide significance. An exceptionally strong association mapped DNA variants to a non-coding region near the chemokine CXCL12 in both European and African ancestries, which overlapped with variants associated with coronary artery disease. Genomic analyses predicted these variants to impact CXCL12 levels, and imaging revealed dominance to develop during fetal life coincident with CXCL12 expression. Reducing Cxcl12 in mice to model the human genetics altered septal artery dominance patterns and caused coronary branches to develop away from Cxcl12 expression domains. Cxcl12 heterozygosity did not compromise overall artery coverage as seen with full deletion, but instead changed artery patterning, reminiscent of the human scenario. Together, our data support CXCL12 as a critical determinant of human coronary artery growth and patterning and lay a foundation for the utilization of developmental pathways to guide future precision medical revascularization therapeutics.
- organism: human
- assay: bulk RNA-seq
- research focus: GWAS / association mapping
- approach: statistical model
- Citations
- 15
- FWCI
- 9.86
- Field percentile
- top 1%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Endocardium-to-coronary artery differentiation during heart development and regeneration involves sequential roles of Bmp2 and Cxcl12/Cxcr4.
Gaetano D’Amato, Ragini Phansalkar, … Kristy Red‐Horse·Developmental CellPeer-reviewed·Nov 1, 2022
- Coronary vessel assembly involves patterned endocardial sprouting and tip-cell-to artery specification
Elena Cano, Jennifer Paech, … Holger Gerhardt·bioRxiv·Dec 20, 2022
- Coronary arterial development is regulated by a Dll4-Jag1-EphrinB2 signaling cascade
Stanislao Igor Travisano, Vera Lúcia Oliveira, … José Luís de la Pompa·eLifePeer-reviewed·Dec 2, 2019
- Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants.
Krishna G. Aragam, Tao Jiang, … Adam S. Butterworth·medRxiv·May 24, 2021
- Genetic loci associated with coronary artery disease harbor evidence of selection and antagonistic pleiotropy
Sean G Byars, Qinqin Huang, … Michael Inouye·bioRxiv·Aug 28, 2016
- A CXCL12 morphogen gradient uncovers lung endothelial heterogeneity and promotes distal vascular growth
Prashant Chandrasekaran, Nicholas M. Negretti, … David B. Frank·bioRxiv·Apr 30, 2022